ID
int64
1
9.11k
age
float64
18
102
death
int64
0
1
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
d.time
int64
3
2.03k
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
income
stringclasses
4 values
scoma
float64
0
100
charges
float64
1.17k
1.44M
totcst
float64
0
633k
totmcst
float64
-102.72
711k
avtisst
float64
1
83
race
stringclasses
5 values
sps
float64
0.2
99.2
aps
float64
0
143
surv2m
float64
0
0.97
surv6m
float64
0
0.95
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
prg6m
float64
0
1
dnr
stringclasses
3 values
dnrday
float64
-88
285
meanbp
float64
0
195
wblc
float64
0
200
hrt
float64
0
300
resp
float64
0
90
temp
float64
31.7
41.7
pafi
float64
12
890
alb
float64
0.4
29
bili
float64
0.1
63
crea
float64
0.1
21.5
sod
float64
110
181
ph
float64
6.83
7.77
glucose
float64
0
1.09k
bun
float64
1
300
urine
float64
0
9k
adlp
float64
0
7
adls
float64
0
7
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
6,501
47.29398
0
female
0
10
1,485
CHF
COPD/CHF/Cirrhosis
1
12
$11-$25k
0
7,790
5,803.7695
5,264.14844
7
hispanic
17.199219
8
0.922974
0.869995
1
0
0
no
0.8
0.75
no dnr
10
80
6.399414
100
24
36.29688
376.1875
null
1.099854
1
136
7.489258
null
null
null
1
0
SIP>=30
0
6,502
51.15698
1
male
1
3
3
MOSF w/Malig
ARF/MOSF
1
8
$11-$25k
0
3,387
2,218.2695
2,290.54883
20
white
37.796875
59
0.271973
0.164978
1
0
0
metastatic
null
null
dnr after sadm
2
75
0
130
36
37.19531
120
2.899902
0.5
1.5
142
7.209961
null
null
null
null
null
<2 mo. follow-up
2.916992
6,503
53.47299
1
female
0
5
395
CHF
COPD/CHF/Cirrhosis
3
11
under $11k
0
3,567
2,547.8691
2,345.22852
18
white
22
39
0.873901
0.789917
1
1
0
no
1
1
no dnr
5
113
8.398438
79
28
36.19531
319
3.399902
0.399963
2.899902
141
7.449219
null
null
null
0
0
no(M2 and SIP pres)
0
6,504
63.98599
1
female
1
7
7
Cirrhosis
COPD/CHF/Cirrhosis
4
16
$11-$25k
0
23,264
16,929.9375
17,669.6562
53
white
47.59375
76
0.082993
0.012999
1
0
0
no
0.3
0.2
dnr after sadm
4
60
17
136
42
36.09375
67
4.199219
11.699219
2.399902
149
7.359375
null
null
null
null
0
<2 mo. follow-up
0
6,505
65.14398
1
male
1
3
3
Colon Cancer
Cancer
2
16
$11-$25k
9
2,223
1,524.2764
1,690.5791
4
white
45.296875
55
0.10199
0.003
1
0
0
metastatic
null
null
dnr after sadm
2
83
19.796875
110
12
35
null
2.799805
11
2.599609
142
null
null
null
null
null
3
<2 mo. follow-up
3
6,506
41.26498
1
male
1
27
27
MOSF w/Malig
ARF/MOSF
6
12
under $11k
9
88,324
57,915.2188
69,530.5625
59.25
white
42.195313
77
0.20697
0.112991
1
0
0
yes
0.5
0.5
dnr after sadm
27
160
0
116
8
34.19531
210
2.699707
9.199219
1.5
143
7.469727
null
null
null
null
0
<2 mo. follow-up
0
6,507
58.245
1
female
1
13
13
Coma
Coma
1
11
$11-$25k
100
98,007
80,836.6875
74,093.5625
49.5
black
37.59375
49
0.004
0.001
22
0
0
no
0.05
0.000125
no dnr
13
125
15.398438
107
29
35.5
57
2.799805
2.299805
1.299805
130
7.469727
null
null
null
null
5
<2 mo. follow-up
5
6,508
74.75696
1
male
0
8
36
ARF/MOSF w/Sepsis
ARF/MOSF
4
10
$11-$25k
0
10,009
7,786.9141
7,523.65625
9.5
white
30.296875
38
0.649902
0.550903
1
0
1
no
0.7
0.5
no dnr
8
109
13.599609
80
22
35.89844
140.8125
3.599609
1.099854
2.899902
133
7.30957
null
null
null
null
6
<2 mo. follow-up
6
6,509
68.64099
1
male
0
14
471
MOSF w/Malig
ARF/MOSF
2
12
under $11k
0
10,229
7,585.3086
7,582.15625
22
black
24
52
0.626953
0.522949
1
0
0
metastatic
0.2
0
dnr after sadm
1
68
0.899902
85
28
38.89844
null
1.899902
1.299805
0.699951
138
null
null
null
null
0
6
SIP>=30
6
6,510
75.01398
1
male
0
7
137
MOSF w/Malig
ARF/MOSF
3
9
$11-$25k
0
4,869
3,544.7383
3,592.54883
15
white
28.5
53
0.578979
0.468994
1
0
0
yes
0.2
0.05
dnr before sadm
-1
59
21.597656
96
38
35.69531
290.4375
3.299805
1
1.299805
126
7.469727
null
null
null
3
4
SIP>=30
4
6,511
69.77698
0
female
0
7
1,475
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
9,604
7,108.6914
7,057.96875
13
white
25.199219
31
0.755981
0.677979
2
0
0
no
0.6
0.6
no dnr
7
99
6.399414
101
26
36.5
130
null
0.5
0.799927
142
7.379883
null
null
null
3
3
no(M2 and SIP pres)
3
6,512
28.02499
1
male
1
5
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
under $11k
0
16,090
12,267.7734
11,788.4297
65
white
32.898438
46
0.805908
0.740967
1
0
0
no
0.1
0.001
dnr after sadm
3
59
21.597656
150
14
39.89844
98.875
2.5
1.5
0.699951
135
7.429688
null
null
null
null
6
<2 mo. follow-up
6
6,513
67.461
1
female
0
4
536
CHF
COPD/CHF/Cirrhosis
3
8
under $11k
0
3,236
2,334.3535
2,174.25977
13
black
31.296875
51
0.674927
0.503906
1
1
0
no
0.9
0.9
no dnr
4
125
7.799805
70
20
36
100
3.299805
0.5
3.899902
135
7.349609
null
null
null
0
null
no(M2 and SIP pres)
0.4948
6,514
41.61298
1
male
0
4
716
Cirrhosis
COPD/CHF/Cirrhosis
3
12
under $11k
0
3,803
2,692.3594
2,550.92969
13
white
25.898438
40
0.803955
0.68396
1
0
0
no
null
null
no dnr
4
57
7.199219
145
20
36.5
357.125
3
2.599609
0.599976
134
7.479492
null
null
null
null
null
null
2.760254
6,515
41.50897
1
female
0
23
180
Coma
Coma
0
12
$11-$25k
44
53,733
35,883.5
41,107.2812
38.666657
black
25.597656
52
0.581909
0.514893
9
0
0
no
0.4
0.4
no dnr
23
65
28.5
140
43
39.19531
448.875
2.299805
1.799805
1.199951
145
7.389648
null
null
null
null
0
no(M2 and SIP pres)
0
6,516
73.41498
1
male
1
30
30
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
39,900
29,680
28,900.6719
34.5
white
25.796875
47
0.623901
0.519897
1
0
0
metastatic
0.7
0.1
dnr after sadm
9
110
9.199219
171
32
36.29688
193.59375
2.399902
0.5
0.599976
134
7.419922
null
null
null
null
7
<2 mo. follow-up
7
6,517
78.28595
0
female
0
5
1,474
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
6,560
5,348.8711
4,956.56641
22
white
15.099609
35
0.875
0.791992
1
0
0
no
0.5
0.5
no dnr
5
57
9.199219
61
16
36
null
4.399414
0.799927
1.5
135
null
null
null
null
0
0
SIP>=30
0
6,518
69.56897
1
male
0
4
174
Lung Cancer
Cancer
3
16
under $11k
0
5,789
3,082.3457
3,216.62891
17
white
20.5
23
0.577881
0.256958
3
0
0
metastatic
0.6
0.3
no dnr
4
113
13
121
24
36.59375
null
null
null
1.199951
138
null
null
null
null
5
5
adl>=4 (>=5 if sur)
5
6,519
65.01599
1
male
0
8
11
COPD
COPD/CHF/Cirrhosis
4
12
$11-$25k
0
13,441
7,388.4766
8,515.82812
20
white
28.699219
51
0.744995
0.598999
1
0
0
no
0.8
0.7
no dnr
8
63
24.597656
126
28
35.79688
200
3.399902
0.699951
2.199707
139
7.369141
null
null
null
0
6
<2 mo. follow-up
6
6,520
74.29999
1
male
1
9
9
MOSF w/Malig
ARF/MOSF
1
13
under $11k
9
40,752
27,083.0156
28,585.4062
42.5
white
33
62
0.227997
0.128998
8
0
0
metastatic
0.05
0.000125
dnr after sadm
1
109
13.798828
117
8
38
280
1.299805
12.699219
3.899902
136
7.379883
null
null
null
null
1
<2 mo. follow-up
1
6,521
39.73199
0
male
0
3
1,458
ARF/MOSF w/Sepsis
ARF/MOSF
4
10
under $11k
0
4,754
3,010.7754
3,389.34961
46
white
18.898438
3
0.916992
0.886963
1
0
0
no
1
1
no dnr
3
95
8.798828
66
24
36
183.65625
4.299805
1.199951
0.899902
138
7.399414
null
null
null
1
0
no(M2 and SIP pres)
0
6,522
30.88599
1
male
1
40
40
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
null
0
169,997
111,276.875
127,505.375
58.25
white
32.59375
70
0.800903
0.734985
1
0
0
no
0.8
0.8
dnr after sadm
39
65
6.199219
120
30
38.79688
116.65625
2.299805
2.5
10.599609
148
7.379883
null
null
null
null
0
<2 mo. follow-up
0
6,523
75.86597
1
female
1
69
69
ARF/MOSF w/Sepsis
ARF/MOSF
2
6
under $11k
9
196,778
140,242.625
144,102.125
51.25
black
27.898438
31
0.562988
0.450989
17
0
0
no
0.4
0.4
dnr after sadm
55
61
19.898438
131
10
36.09375
400
null
null
1.899902
132
7.30957
null
null
null
null
0
adl>=4 (>=5 if sur)
0
6,524
64.33099
1
female
0
10
23
Lung Cancer
Cancer
1
12
$25-$50k
0
7,942
5,353.5312
6,965.60938
14.5
white
27.796875
18
0.439941
0.130981
1
0
0
metastatic
0.5
0.1
no dnr
10
79
8.199219
110
24
38
null
2.699707
0.299988
0.699951
128
null
null
null
null
2
3
<2 mo. follow-up
3
6,525
66.64197
0
male
0
21
1,454
COPD
COPD/CHF/Cirrhosis
2
3
under $11k
0
21,567
14,687.9609
16,171.9844
14.333328
white
24.5
24
0.800903
0.679932
1
0
0
no
0.9
0.8
no dnr
21
109
16.398438
81
32
35.29688
208
3
0.799927
0.799927
138
7.389648
null
null
null
1
3
SIP>=30
3
6,526
64.62695
0
female
0
18
1,452
ARF/MOSF w/Sepsis
ARF/MOSF
2
7
under $11k
0
37,273
24,393.25
28,367.0625
31.333328
black
34.09375
64
0.615967
0.510986
1
1
0
no
0.8
0.8
no dnr
18
53
20.398438
58
48
36.09375
207.75
2.899902
0.599976
4.299805
146
7.229492
null
null
null
0
0
no(M2 and SIP pres)
0
6,527
80.02698
1
male
1
4
4
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
0
15,597
10,053.7109
11,374.6484
41
white
46.5
63
0.107986
0.045998
6
0
0
no
0.5
0.5
dnr before sadm
-4
29
9.099609
232
46
36
159.15625
2.699707
0.399963
1.199951
137
7.40918
null
null
null
null
null
<2 mo. follow-up
2.819824
6,528
60.87097
1
male
1
4
4
ARF/MOSF w/Sepsis
ARF/MOSF
3
8
under $11k
100
12,379
6,517.9336
7,455.55859
54
white
63.796875
104
0
0
1
0
0
no
null
null
no dnr
4
34
15.599609
136
30
35.29688
42
2.199707
3.199707
5.599609
132
7.119141
null
null
null
null
null
<2 mo. follow-up
3.575195
6,529
61.81799
0
male
0
7
1,450
ARF/MOSF w/Sepsis
ARF/MOSF
2
13
$25-$50k
9
19,615
9,873.7734
11,146.9141
24
white
18.597656
28
0.844971
0.791992
3
1
0
no
0.9
0.9
no dnr
7
102
10.798828
71
36
36.19531
320
2.599609
0.599976
1.199951
141
7.479492
null
null
null
0
0
no(M2 and SIP pres)
0
6,530
66.98395
1
male
0
7
99
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
5,761
3,532.8262
3,826.33984
10.5
white
21.796875
22
0.795898
0.670898
1
0
0
yes
0.9
0.8
no dnr
7
87
13.099609
114
24
36
213.5625
null
0.399963
1.299805
139
7.369141
null
null
null
1
0
no(M2 and SIP pres)
0
6,531
71.88995
1
female
0
5
783
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
5,999
3,557.8906
3,993.13867
20
white
15.398438
27
0.879883
0.800903
1
0
0
no
0.8
0.65
no dnr
5
75
4.399414
68
26
36.59375
291.25
3.599609
0.699951
0.799927
138
7.389648
null
null
null
2
0
no(M2 and SIP pres)
0
6,532
63.34
0
male
0
10
1,448
ARF/MOSF w/Sepsis
ARF/MOSF
5
7
under $11k
0
13,169
7,743.918
8,770.5625
16.5
white
15.599609
23
0.900879
0.86499
1
0
0
no
0.9
0.8
no dnr
10
62
7.399414
81
28
36.39844
318.5
2.799805
1
1.199951
136
7.399414
null
null
null
0
0
no(M2 and SIP pres)
0
6,533
69.99896
1
female
1
4
4
CHF
COPD/CHF/Cirrhosis
4
6
under $11k
0
2,775
1,863.1728
2,041.61914
25
black
36.195313
67
0.53894
0.339966
1
1
1
no
0.8
0.6
no dnr
4
121
5.399414
120
32
36.29688
100
3.099609
0.5
2.5
145
7.149414
null
null
null
3
5
<2 mo. follow-up
5
6,534
43.29099
1
male
0
16
238
Cirrhosis
COPD/CHF/Cirrhosis
3
10
under $11k
0
32,387
21,183.4062
25,112.9375
29.333328
white
30.398438
35
0.718994
0.562988
1
0
0
no
0.8
0.8
no dnr
16
108
11.398438
56
10
35.69531
280
2.899902
3
0.399963
128
7.389648
null
null
null
null
0
no(M2 and SIP pres)
0
6,535
66.81696
1
male
0
38
48
Coma
Coma
0
12
null
9
71,849
48,105.375
52,823.6562
40
white
24.5
34
0.625977
0.563965
1
0
0
no
0.2
0.1
no dnr
38
110
7.699219
57
10
36.79688
190
2.299805
5.5
1.299805
153
7.429688
null
null
null
null
0
<2 mo. follow-up
0
6,536
53.66699
0
female
0
6
1,444
COPD
COPD/CHF/Cirrhosis
3
11
under $11k
0
5,740
3,372.3379
3,686.18945
12
white
22
21
0.863892
0.773926
1
0
0
yes
0.8
0.7
no dnr
6
100
8.898438
118
22
36.29688
264
null
null
0.699951
133
7.389648
null
null
null
2
1
adl>=4 (>=5 if sur)
1
6,537
48.25198
0
female
0
3
1,442
CHF
COPD/CHF/Cirrhosis
4
7
under $11k
0
2,119
1,352.2275
1,493.7998
2
black
20.796875
23
0.895996
0.825928
1
0
0
no
null
null
no dnr
3
127
8.199219
84
20
36.39844
361.875
2.799805
0.699951
1.699951
137
7.449219
null
null
null
null
null
no(M2 and SIP pres)
2.688965
6,538
87.836
1
female
0
31
209
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
9
63,726
41,403.5
46,481.4062
31.5
white
22.5
26
0.696899
0.605957
2
0
0
no
0.6
0.6
no dnr
31
123
12.398438
113
8
38.69531
290
3
1
1.899902
143
7.40918
null
null
null
null
0
adl>=4 (>=5 if sur)
0
6,539
84.55298
1
female
1
31
31
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
under $11k
26
69,005
41,842.9062
45,580.8438
22.5
white
30
44
0.387939
0.268982
7
0
0
no
0.5
0.2
dnr after sadm
5
112
15
114
24
36.19531
null
2.099609
null
2.399902
128
null
null
null
null
null
1
<2 mo. follow-up
1
6,540
64.91998
1
male
0
3
47
Lung Cancer
Cancer
1
8
under $11k
0
3,005
1,091.9355
1,457.50977
20
white
19
16
0.665894
0.36499
1
0
0
metastatic
0.5
0.2
no dnr
3
107
12.798828
118
20
36.69531
null
3.599609
0.899902
1
136
null
null
null
null
null
0
<2 mo. follow-up
0
6,541
79.77295
1
female
1
7
7
Lung Cancer
Cancer
2
10
under $11k
9
9,584
6,354.2695
8,414.96875
6
white
28
25
0.25
0.031998
6
0
0
metastatic
0
0
dnr after sadm
1
76
15.398438
107
24
36.09375
null
2.899902
null
0.899902
134
null
null
null
null
null
0
<2 mo. follow-up
0
6,542
69.125
0
female
0
22
1,440
ARF/MOSF w/Sepsis
ARF/MOSF
4
15
under $11k
0
36,693
null
null
28.666656
white
19.597656
33
0.819946
0.759888
5
1
0
no
0.5
0.4
no dnr
22
64
4.399414
72
12
36.19531
280.625
2.299805
0.5
1.5
143
7.5
null
null
null
null
null
no(M2 and SIP pres)
2.924316
6,543
54.62799
1
male
0
35
226
MOSF w/Malig
ARF/MOSF
2
9
under $11k
9
68,558
45,297.6562
55,132.9062
30
black
34.796875
60
0.272949
0.164978
17
0
0
yes
0.3
0.3
dnr after sadm
16
56
1.199951
138
12
39
220
2.299805
3.399902
1.899902
138
7.40918
null
null
null
4
5
SIP>=30
5
6,544
61.76599
1
female
1
4
4
Coma
Coma
3
null
$25-$50k
100
10,765
5,051.3945
5,734.13672
47
white
28.796875
35
0.066986
0.035995
1
0
0
yes
null
null
dnr after sadm
3
135
26.699219
144
12
39.5
130
3.099609
0.399963
0.899902
149
7.399414
null
null
null
null
null
<2 mo. follow-up
3.595215
6,545
28.50699
0
male
0
12
1,435
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
null
0
36,646
21,162.4375
23,650.3594
43.5
black
26.796875
45
0.858887
0.809937
3
0
0
no
0.4
0.3
no dnr
12
121
21.199219
69
22
36.29688
173.3125
2.699707
0.5
5.299805
134
7.40918
null
null
null
null
0
no(M2 and SIP pres)
0
6,546
62.73798
1
male
1
7
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
19,132
12,136.4609
13,689.2969
52
black
42.59375
57
0.220978
0.123993
1
0
0
metastatic
0
0
dnr after sadm
3
45
12
157
24
38.19531
64
2.399902
0.599976
0.5
133
7.369141
null
null
null
null
2
<2 mo. follow-up
2
6,547
24.47899
1
female
1
18
18
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
9
82,030
53,853.9375
60,715.7812
48.333313
white
24.097656
38
0.885986
0.844971
2
0
0
no
0.8
0.8
no dnr
18
113
15.298828
138
24
39.69531
297.125
1.899902
1.199951
1.5
134
7.379883
null
null
null
null
0
<2 mo. follow-up
0
6,548
62.05899
1
male
0
15
213
Lung Cancer
Cancer
4
3
under $11k
0
12,205
8,258.0469
10,778.9688
8
white
10.798828
13
0.816895
0.605957
1
0
0
metastatic
0.2
0.04
dnr before sadm
-1
97
null
74
24
35.59375
null
4.099609
0.299988
0.899902
132
null
null
null
null
1
1
SIP>=30
1
6,549
66.43396
1
male
0
11
128
ARF/MOSF w/Sepsis
ARF/MOSF
4
null
under $11k
0
18,040
11,452.9219
12,571.5078
28
white
28.796875
43
0.7229
0.637939
1
1
0
no
0.5
0.5
no dnr
11
105
24.398438
124
25
37.79688
124
4.699219
0.699951
1.399902
139
7.389648
null
null
null
null
null
SIP>=30
3.20752
6,550
58.37097
1
female
0
7
230
COPD
COPD/CHF/Cirrhosis
2
10
under $11k
0
7,453
4,463.0195
4,921.30859
13
white
16
21
0.919922
0.86499
1
1
0
no
0.8
0.6
no dnr
7
96
15
107
28
36.19531
380
4.799805
0.799927
1
150
7.419922
null
null
null
0
0
SIP>=30
0
6,551
65.52997
1
male
0
6
421
Cirrhosis
COPD/CHF/Cirrhosis
5
null
null
0
4,795
2,914.5606
3,083.9082
4
white
25
31
0.660889
0.485962
1
1
0
no
0.5
0.5
no dnr
6
96
2
112
20
36
null
3.099609
6
0.899902
135
null
null
null
null
null
null
null
3.248047
6,552
66.90997
1
female
0
12
673
MOSF w/Malig
ARF/MOSF
1
11
under $11k
0
27,529
17,784.2812
19,595.6094
20.5
white
21.097656
31
0.639893
0.53894
5
0
0
metastatic
0.5
0.3
no dnr
12
103
7.699219
103
30
36.79688
247.5
2.699707
0.899902
1.799805
133
7.40918
null
null
null
0
0
no(M2 and SIP pres)
0
6,553
64.11499
0
male
0
6
1,428
COPD
COPD/CHF/Cirrhosis
2
9
under $11k
0
9,411
6,061.9492
6,945.89844
25
white
20.597656
28
0.861938
0.771973
1
0
0
no
0.9
0.75
no dnr
6
79
18.5
77
26
35.39844
188.5625
3.799805
0.699951
0.799927
139
7.479492
null
null
null
1
0
null
0
6,554
81.91095
1
male
0
13
907
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
$25-$50k
0
34,636
20,214.7344
22,389.5469
45.5
white
29.796875
56
0.56897
0.457947
4
0
0
no
0.5
0.5
no dnr
13
110
9.298828
124
25
37.59375
79
1.5
1.399902
1.099854
148
7.139648
null
null
null
null
0
null
0
6,555
32.81299
1
male
1
154
154
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
null
0
479,465
316,924.5
376,922
51
white
37.09375
93
0.641968
0.541992
10
0
0
no
0.7
0.5
dnr after sadm
154
58
24.699219
156
14
38.09375
204
4.199219
11.199219
8.398438
130
7.289062
null
null
null
null
0
adl>=4 (>=5 if sur)
0
6,556
31.20299
0
male
0
5
1,427
ARF/MOSF w/Sepsis
ARF/MOSF
4
13
under $11k
37
7,541
4,971.6055
5,624.46875
23
white
21.796875
21
0.852905
0.802979
1
0
0
no
0.95
0.9
no dnr
5
77
18
114
34
36.79688
574
2.899902
0.599976
0.799927
137
7.349609
null
null
null
0
null
no(M2 and SIP pres)
0.4948
6,557
82.58698
1
female
1
164
164
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
under $11k
26
289,468
231,848.75
271,467.25
52
white
27.898438
40
0.328979
0.213989
36
0
0
yes
0.5
0.5
dnr after sadm
157
162
12.398438
130
12
36.69531
325.6875
null
1.599854
2
131
7.349609
null
null
null
null
2
adl>=4 (>=5 if sur)
2
6,558
48.04398
1
male
0
10
16
Cirrhosis
COPD/CHF/Cirrhosis
2
7
under $11k
0
9,761
6,477.8945
6,694.03906
13.5
white
31.199219
40
0.664917
0.490967
1
0
0
no
0.95
0.85
no dnr
10
85
11.798828
72
28
36.69531
null
2.399902
24.199219
0.5
131
null
null
null
null
0
0
<2 mo. follow-up
0
6,559
69.63696
1
male
0
5
6
MOSF w/Malig
ARF/MOSF
2
15
$11-$25k
9
11,128
7,264.6836
8,283.25
30
white
30.597656
57
0.401978
0.282959
1
0
0
metastatic
0.8
0.7
no dnr
5
64
12.398438
131
39
36.19531
133.3125
2.099609
1
0.899902
135
7.539062
null
null
null
6
null
<2 mo. follow-up
4.527397
6,560
34.116
1
female
0
5
98
Cirrhosis
COPD/CHF/Cirrhosis
4
7
under $11k
0
9,156
6,053.8008
7,153.47656
27
hispanic
18.5
27
0.901978
0.834961
2
0
0
no
0.4
0.3
no dnr
5
104
6.399414
107
28
38.19531
257.125
2.699707
2.599609
0.899902
139
7.509766
null
null
null
0
null
Coma or Intub
0.4948
6,561
73.39398
1
female
1
8
8
Coma
Coma
0
12
null
55
34,045
22,063
25,459.0781
27
white
17
28
0.468994
0.395996
7
0
0
no
0.75
0.6
dnr after sadm
5
126
17.398438
70
34
37.79688
256.625
2.5
0.599976
0.699951
136
7.5
null
null
null
null
0
<2 mo. follow-up
0
6,562
65.073
1
male
0
28
53
ARF/MOSF w/Sepsis
ARF/MOSF
3
11
under $11k
41
44,964
29,248.8594
31,840.6562
24.25
white
24.296875
35
0.67395
0.577881
1
1
0
no
1
0.8
no dnr
28
103
11.599609
70
34
37.79688
124.48438
2.199707
0.399963
0.699951
133
7.449219
null
null
null
null
4
<2 mo. follow-up
4
6,563
42.905
1
male
1
41
41
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
100
124,495
80,604.5625
87,536.0625
54
black
33
49
0.267944
0.16098
2
0
0
no
0.5
0.5
dnr after sadm
41
51
13.5
111
10
36.59375
215
2.699707
2
3
136
7.269531
null
null
null
null
null
<2 mo. follow-up
3.634766
6,564
79.09698
1
female
0
13
23
ARF/MOSF w/Sepsis
ARF/MOSF
3
9
under $11k
0
14,050
9,417.7109
10,638.3438
18
white
33.796875
37
0.535889
0.420959
1
0
0
no
0.9
0.7
dnr after sadm
3
132
14.298828
10
22
35.39844
132.625
3.399902
0.699951
1.199951
140
7.5
null
null
null
0
1
<2 mo. follow-up
1
6,565
30.19299
1
male
0
36
74
Coma
Coma
0
12
$11-$25k
55
46,838
31,740.5469
36,188.5312
26.25
hispanic
20.898438
20
0.786987
0.745972
1
0
0
no
0.9
0.9
no dnr
36
132
24.097656
131
24
37.79688
413.3125
3.399902
0.399963
1.099854
146
7.399414
null
null
null
null
0
adl>=4 (>=5 if sur)
0
6,566
41.66998
0
male
0
22
1,416
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
under $11k
26
37,499
25,443.2031
26,909.9219
19.666656
white
27.898438
46
0.705933
0.61792
7
0
0
no
1
0.95
no dnr
22
129
9.099609
131
26
38.79688
352
2.5
0.299988
3.399902
155
7.40918
null
null
null
null
0
no(M2 and SIP pres)
0
6,567
55.06897
0
male
0
10
1,414
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
$25-$50k
44
16,669
11,251.7812
12,750.375
28
white
29.597656
41
0.592896
0.484985
1
0
0
no
0.5
0.3
no dnr
10
119
7.399414
150
28
39.09375
471.375
2.899902
6.5
0.799927
129
7.469727
null
null
null
null
0
no(M2 and SIP pres)
0
6,568
31.24699
1
female
0
6
1,083
Cirrhosis
COPD/CHF/Cirrhosis
3
11
under $11k
0
4,111
2,825.4961
3,081.78906
3
black
24.796875
47
0.863892
0.774902
1
0
0
no
1
0.9
no dnr
6
57
6.199219
79
16
35.79688
null
2.599609
5.899414
1.5
133
null
null
null
null
0
7
SIP>=30
7
6,569
27.10699
0
female
0
22
1,416
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
9
35,273
23,438.5156
26,274.6562
37.333313
white
26.5
47
0.865967
0.819946
1
0
0
no
0.8
0.8
no dnr
22
115
18.5
191
27
38.19531
285.6875
1.799805
3.599609
0.5
135
7.439453
null
null
null
null
7
no(M2 and SIP pres)
7
6,570
66.20398
1
male
1
22
22
COPD
COPD/CHF/Cirrhosis
4
10
under $11k
0
62,927
39,654.5312
45,808.2188
41.666657
white
37
54
0.545898
0.347961
1
0
0
no
0.8
0.6
dnr after sadm
12
64
14.398438
141
48
38.39844
80
2.299805
1.5
0.699951
146
7.449219
null
null
null
null
null
<2 mo. follow-up
3.825195
6,571
58.034
0
female
0
25
1,410
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
53,220
34,428.3438
38,644.9062
33.75
white
24.097656
30
0.805908
0.741943
3
0
0
no
0.25
0.3
no dnr
25
103
13.699219
114
10
39
202
2.099609
2.799805
0.699951
144
7.399414
null
null
null
null
6
SIP>=30
6
6,572
35.44998
1
male
0
21
775
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
9
37,261
23,804.8125
26,621.7812
31.666656
white
19.5
20
0.908936
0.875977
1
0
0
no
0.8
0.6
no dnr
21
119
12.898438
60
12
36.39844
372
2.299805
0.899902
0.899902
143
7.449219
null
null
null
null
0
no(M2 and SIP pres)
0
6,573
52.909
1
female
1
27
27
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
under $11k
9
92,986
61,717.8125
69,139.9375
44.25
white
35.695313
62
0.528931
0.41394
7
0
0
no
0.65
0.65
dnr after sadm
27
63
12
78
8
36
185
1.5
21.597656
4
135
7.369141
null
null
null
null
0
<2 mo. follow-up
0
6,574
28.23
0
female
0
38
1,409
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
under $11k
0
46,400
30,953.7969
33,497.4062
16.25
hispanic
25.097656
16
0.872925
0.827881
4
0
0
no
1
1
no dnr
38
81
4.199219
124
32
38.79688
480.9375
2.799805
1.099854
0.699951
135
7.439453
null
null
null
0
0
no(M2 and SIP pres)
0
6,575
82.22595
1
male
0
43
206
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$25-$50k
26
70,934
44,802.0312
49,305.2188
30.25
white
28
28
0.418945
0.29895
3
0
0
yes
0.35
0.3
dnr after sadm
1
63
4
101
9
39.19531
128
2.599609
2.399902
0.799927
142
7.449219
null
null
null
null
1
adl>=4 (>=5 if sur)
1
6,576
71.82495
0
female
0
12
1,406
ARF/MOSF w/Sepsis
ARF/MOSF
6
11
$11-$25k
26
14,032
9,681.8359
10,911.0625
21.5
black
26.5
45
0.647949
0.54895
1
1
1
no
0.25
0.2
no dnr
12
103
55.398438
111
22
37
571.375
3.399902
0.699951
5.699219
135
7.449219
null
null
null
null
3
adl>=4 (>=5 if sur)
3
6,577
85.16394
1
female
1
10
10
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
9
75,455
49,430.6562
57,870.2812
52.5
white
34.195313
66
0.329956
0.214996
11
0
0
no
0.1
0.001
dnr after sadm
9
52
8.199219
122
20
38
198
1.799805
25.296875
0.699951
140
7.399414
null
null
null
null
4
<2 mo. follow-up
4
6,578
48.42398
0
female
0
20
1,403
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
36,511
23,229.4531
26,954.3125
31.666656
white
34.796875
50
0.581909
0.471985
3
0
0
yes
0.5
0.45
no dnr
20
56
21.796875
116
30
38.80469
73.32812
1.799805
0.899902
0.599976
143
7.40918
null
null
null
null
0
no(M2 and SIP pres)
0
6,579
75.44098
1
male
0
5
620
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
4,164
2,751.9941
2,974.60938
12
white
17.796875
20
0.839966
0.737915
1
0
0
no
0.7
0.6
no dnr
5
90
10
53
24
36
207.40625
3.699707
0.5
1.099854
139
7.399414
null
null
null
0
0
SIP>=30
0
6,580
62.20898
1
female
1
3
3
Coma
Coma
0
null
under $11k
100
6,400
3,844.5488
4,382.50781
28
white
23.097656
28
0.259949
0.191986
1
0
0
no
0
0
no dnr
3
60
27.398438
136
8
36.29688
239.21875
3.299805
0.5
1.199951
145
7.069336
null
null
null
null
0
<2 mo. follow-up
0
6,581
35.93997
1
male
0
5
242
CHF
COPD/CHF/Cirrhosis
5
12
$11-$25k
0
3,809
2,524.8672
2,788.51953
16
black
16.699219
14
0.941895
0.900879
1
0
0
no
null
null
no dnr
5
83
3.599609
79
20
35
null
3.199707
3.199707
0.899902
139
null
null
null
null
null
null
no(M2 and SIP pres)
2.685059
6,582
61.25897
1
female
1
5
5
ARF/MOSF w/Sepsis
ARF/MOSF
5
4
under $11k
100
90,017
60,139.4688
66,903.125
60
white
36.695313
68
0.036995
0.009998
19
1
0
no
0
0
dnr after sadm
5
59
18.796875
117
12
35.69531
133.3125
2.099609
11.398438
1.199951
146
7.219727
null
null
null
null
null
<2 mo. follow-up
5.123047
6,583
70.84698
1
male
0
5
296
Lung Cancer
Cancer
3
9
under $11k
0
2,911
2,018.918
2,635.30859
11
white
15.199219
22
0.72998
0.458984
1
0
0
metastatic
0.8
0.5
no dnr
5
99
44.898438
110
20
36.5
null
4.099609
0.5
1.299805
140
null
null
null
null
0
1
no(M2 and SIP pres)
1
6,584
55.56998
1
male
0
16
477
ARF/MOSF w/Sepsis
ARF/MOSF
6
12
under $11k
0
21,393
14,453.625
15,827.1641
23.666656
white
33.296875
63
0.68396
0.590942
1
0
0
no
0.7
0.65
no dnr
16
140
1.099854
200
32
36
290.4375
2.5
2.299805
1.299805
133
7.539062
null
null
null
0
0
no(M2 and SIP pres)
0
6,585
36.67899
0
female
0
9
1,397
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
0
20,380
13,409.4688
14,850.6797
41.5
white
30
60
0.817993
0.756958
1
0
0
no
0.5
0.45
no dnr
9
139
18.898438
114
10
39.5
117.5
2.299805
0.899902
10.398438
135
7.439453
null
null
null
0
0
SIP>=30
0
6,586
65.66199
1
male
0
17
75
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
33,079
21,716.5156
24,629.75
26.666656
black
33.296875
81
0.474976
0.355957
1
0
0
metastatic
0.5
0.3
no dnr
17
56
0.599976
122
28
38.19531
296
1.899902
2.199707
1.199951
131
7.419922
null
null
null
null
0
no(M2 and SIP pres)
0
6,587
65.45898
1
female
0
7
449
COPD
COPD/CHF/Cirrhosis
1
12
under $11k
0
5,609
3,537.2305
3,705.11914
7
white
19.597656
23
0.865967
0.778931
1
0
0
no
0.8
0.8
no dnr
7
79
8.199219
107
28
36.5
292
3.699707
0.299988
0.5
140
7.389648
null
null
null
0
0
no(M2 and SIP pres)
0
6,588
68.78894
1
male
0
4
450
Cirrhosis
COPD/CHF/Cirrhosis
3
11
$11-$25k
0
3,005
2,012.7266
2,197.97852
7
white
19.597656
38
0.743896
0.596924
1
1
0
no
0.9
0.9
no dnr
4
65
5.599609
61
20
36.69531
380.9375
3
2.399902
1.699951
134
7.5
null
null
null
0
0
no(M2 and SIP pres)
0
6,589
62.26099
0
male
0
53
1,395
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
55
88,038
57,035.4062
62,331.4375
43.25
white
23.597656
35
0.540894
0.426941
21
0
0
no
0.7
0.6
no dnr
53
61
20.097656
118
40
38
440
2
1
0.599976
138
7.449219
null
null
null
null
null
null
3.312988
6,590
46.086
0
female
0
4
1,392
Lung Cancer
Cancer
1
11
$11-$25k
0
4,690
3,126.9766
3,534.08984
18
black
11.298828
11
0.833984
0.638916
1
0
0
metastatic
0.1
0.001
no dnr
4
112
3.899902
98
20
37.39844
null
3.799805
0.199982
1.299805
139
null
null
null
null
0
0
no(M2 and SIP pres)
0
6,591
66.21198
1
male
1
4
4
Lung Cancer
Cancer
3
12
$11-$25k
0
6,481
4,199.7734
4,579.36719
23
white
42.09375
31
0.068985
0.001
1
0
0
metastatic
0.1
0.001
dnr after sadm
1
69
12.599609
96
28
35
90
2.899902
1.099854
0.599976
130
7.209961
null
null
null
null
6
<2 mo. follow-up
6
6,592
65.44598
1
male
0
20
461
ARF/MOSF w/Sepsis
ARF/MOSF
5
13
null
0
46,758
30,252.8594
34,726.9688
38.333313
white
54.59375
85
0.036995
0.009998
1
1
0
yes
0.7
0.6
no dnr
20
33
40.398438
167
38
36
360
2.799805
1.599854
5.899414
126
7.40918
null
null
null
null
0
null
0
6,593
54.98199
1
male
0
33
393
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
under $11k
0
59,155
39,054.875
42,843.2188
36
white
32.695313
75
0.61792
0.513916
11
0
0
no
0.5
0.5
no dnr
33
129
21.898438
178
34
36.79688
172
1.899902
0.599976
3.299805
134
7.509766
null
null
null
null
6
null
6
6,594
80.02197
1
female
1
6
6
MOSF w/Malig
ARF/MOSF
2
16
null
0
27,433
18,217.9375
24,389.2188
48
white
26.898438
38
0.537964
0.42395
6
0
0
yes
0.3
0.25
dnr before sadm
0
72
1.199951
116
10
36.89844
215
1.299805
1.199951
1.299805
138
7.369141
null
null
null
null
5
<2 mo. follow-up
5
6,595
61.54099
0
male
0
12
1,392
COPD
COPD/CHF/Cirrhosis
4
8
under $11k
0
15,302
9,206.6484
11,093.1172
16
white
24.398438
48
0.831909
0.725952
1
0
0
no
0.9
0.85
no dnr
12
77
8.599609
126
38
36.19531
233.3125
null
1.199951
0.899902
135
7.429688
null
null
null
0
0
SIP>=30
0
6,596
64.15295
1
female
1
60
60
MOSF w/Malig
ARF/MOSF
3
10
under $11k
37
93,140
64,560.9062
67,899.875
25.5
black
15.298828
34
0.592896
0.484985
14
1
0
metastatic
0.6
0.5
dnr after sadm
32
115
10.398438
67
24
38.19531
347.5625
2.299805
0.599976
1.099854
132
7.469727
null
null
null
null
null
null
4.288086
6,597
62.04498
1
male
0
10
667
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
7,436
5,171.5898
5,351.72656
9.5
white
21.398438
37
0.855957
0.761963
1
0
0
no
0.9
0.7
no dnr
10
101
4.699219
91
26
36.59375
377.75
3.399902
0.599976
2.399902
143
7.25
null
null
null
1
null
no(M2 and SIP pres)
1.1669
6,598
32.534
0
male
0
49
1,390
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
9
89,321
56,365.625
62,199.4062
40
white
38.09375
64
0.641968
0.540894
2
0
0
no
0.6
0.5
no dnr
49
117
3.099609
147
50
40.5
126.25
2.899902
0.599976
0.799927
133
7.269531
null
null
null
null
7
adl>=4 (>=5 if sur)
7
6,599
70.836
0
female
0
7
1,391
CHF
COPD/CHF/Cirrhosis
4
12
under $11k
0
6,396
4,260.0547
5,020.52734
9.5
white
9.099609
29
0.914917
0.855957
1
1
0
yes
0.95
0.9
no dnr
7
72
6.299805
63
20
36.5
null
4.5
0.5
1.299805
138
null
null
null
null
0
0
no(M2 and SIP pres)
0
6,600
44.35599
0
male
0
14
1,389
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
0
14,332
9,368.1875
9,858.16406
11.666664
white
22.199219
18
0.918945
0.862915
1
0
0
no
0.9
0.9
no dnr
14
116
4.899414
86
28
36.29688
157.125
3.099609
0.5
1.099854
140
7.369141
null
null
null
0
1
no(M2 and SIP pres)
1